内在价值

IGNT latest financial reports are more than 9 years old.
IGNT doesn't have a meaningful market cap.
暂无 IGNT 的相关数据

数据不足,无法可靠地计算 Ingen Technologies Inc 的内在价值。

我们的估值真的有效吗? 查看回测结果 .

IGNT 的替代投资选择

基本面分析

Ingen Technologies 做什么

医疗保健 Health Care

Ingen Technologies, Inc. engages in the manufacture of respiratory medical devices. The company is headquartered in Riverside, California. The company went IPO on 2001-07-11. The firm holds the manufacturing and marketing platforms to produce its core medical product line, referred to as Oxyview and Smart Nasal Cannula. The firm develops products for the treatment of chronic obstructive pulmonary disease (COPD), such as chronic bronchitis, emphysema and asthmatic bronchitis, all of which obstruct airflow from the lungs.

总部
美国 US
上市日期
2001年7月11日
阅读完整公司概况
查看公司概况
财务数据
运营效率

利润瀑布图
Ingen Technologies Inc

华尔街目标价

资本回报

回购收益率
尚未解锁
偿债收益率
尚未解锁

竞争格局